The number of Alzheimer's patients will increase sharply in the future partly due to the aging of the population. Not only in the elderly but also in young adults.
We now know that there is a genetic component but our understanding of the disease, its origin and its treatment is still very limited.
The experienced teams of Prof. Dr. Bart Dermaut and Dr. Tim Van Langenhove hope to change this. They specialize in genetic analysis and clinical-diagnostic research of this disease and related neurodegenerative disorders.
The Fund enables them to take faster and bigger steps in their research.